Iradimed Corporation (NASDAQ:IRMD) Short Interest Update

Iradimed Corporation (NASDAQ:IRMD - Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 112,900 shares, a growth of 11.0% from the February 29th total of 101,700 shares. Based on an average daily trading volume, of 54,200 shares, the short-interest ratio is presently 2.1 days. Currently, 1.4% of the shares of the company are short sold.

Iradimed Trading Down 0.4 %

IRMD stock traded down $0.19 during trading hours on Tuesday, hitting $42.71. 31,997 shares of the stock were exchanged, compared to its average volume of 55,533. The firm has a market capitalization of $540.71 million, a P/E ratio of 31.40 and a beta of 0.82. The company has a 50-day simple moving average of $43.81 and a two-hundred day simple moving average of $43.26. Iradimed has a 12 month low of $36.12 and a 12 month high of $51.04.

Iradimed (NASDAQ:IRMD - Get Free Report) last posted its quarterly earnings data on Thursday, February 8th. The medical equipment provider reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.01). The firm had revenue of $17.45 million for the quarter. Iradimed had a return on equity of 24.62% and a net margin of 26.22%.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Resource Consulting Group Inc. bought a new position in shares of Iradimed in the fourth quarter worth $4,889,000. Soleus Capital Management L.P. increased its position in shares of Iradimed by 8.8% in the fourth quarter. Soleus Capital Management L.P. now owns 745,004 shares of the medical equipment provider's stock worth $21,076,000 after purchasing an additional 60,314 shares during the period. BlackRock Inc. increased its position in shares of Iradimed by 11.9% in the second quarter. BlackRock Inc. now owns 495,965 shares of the medical equipment provider's stock worth $23,677,000 after purchasing an additional 52,655 shares during the period. Bares Capital Management Inc. increased its position in shares of Iradimed by 21.1% in the fourth quarter. Bares Capital Management Inc. now owns 271,300 shares of the medical equipment provider's stock worth $7,675,000 after purchasing an additional 47,298 shares during the period. Finally, Millennium Management LLC increased its position in shares of Iradimed by 274.7% in the fourth quarter. Millennium Management LLC now owns 59,344 shares of the medical equipment provider's stock worth $1,679,000 after purchasing an additional 43,507 shares during the period. Institutional investors own 92.34% of the company's stock.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.